MEL-PLEX partner Prof Francesco Cecconi and his team at the Danish Cancer Society Research Center was awarded DKK 3,820,000.00 (~ €515,000.00) over the next 3 years to support the project entitled “The pro-autophagic tumor suppressor AMBRA1 as a novel therapeutic target for melanoma”.
A health fact sheet published by the European Commission this month (August 2017) features the MEL-PLEX programme among the projects funded to tackle melanoma skin.
The fact sheet can be downloaded here.
On June 28th MEL-PLEX Project Coordinator Prof Markus Rehm received the “Ireland’s Champions of EU Research” recognition awarded by Enterprise Ireland on a special ceremony hosted at the Royal Hospital Kilmainham in Dublin.
The consortium partner OncoMark received a Special Award for its high success in EU funded projects.
More information can be found here.
The European Association of System Medicine (EASyM) is the implementation of Systems Medicine in European clinical research and healthcare. EASyM has been initiated by the European FP7-funded Coordinating Action Systems Medicine (CASyM). EASyM is a charitable association open to everyone with an interest in personalised medicine and systems medicine.
EASyM was founded on 30th September 2015 in Brussels by 27 medical doctors, researchers and health care stakeholders from 12 different countries.
The meeting will take place in Berlin on October 26th-28th, 2016. More information can be found here.
The “Future of the Doctorate” conference organised by the European Commission in Riga during the EU Presidency in Latvia has attracted scientists and policy makers from Europe and abroad. The MEL-PLEX ITN, represented by Prof Thomas Sauter (Chair of the Training Committee) and Dr Isabela Aparicio (Programme Manager) was invited to contribute with a talk about the challenges and opportunities during the implementation of Marie Skłodowska-Curie Actions training networks. Prof Sauter delivered a talk emphasizing our implementation strategies and challenges we are overcoming.